We are live on ! Find out more
VANI icon

Vivani Medical

22 hedge funds and large institutions have $1.28M invested in Vivani Medical in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

58% more capital invested

Capital invested by funds: $809K → $1.28M (+$473K)

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

10% more funds holding

Funds holding: 2022 (+2)

0.37% less ownership

Funds ownership: 1.36%0.99% (-0.37%)

Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
7
Reduced
2
Closed
6
Calls
Puts
Net Calls
Net Calls Change

VANI Hedge Fund Activity: Q4 2020 in Review

22 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q4 2020, worth a combined $1.28M — up 58% from $809K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new VANI positions and 6 closed out — a net gain of 2 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $324K. The largest seller was Versant Venture Management, exiting entirely with an estimated $484K sold.

  • 22 institutional investors held Vivani Medical (VANI) as of Q4 2020, up from 20 in Q3 2020.
  • Funds reported $1.28M of Vivani Medical stock for Q4 2020, up 58% quarter-over-quarter.
  • 8 funds opened new Vivani Medical positions in Q4 2020 and 6 closed out, a net change of +2 holders.
  • The largest Vivani Medical buyer in Q4 2020 was Vanguard Group, an estimated $324K added.
  • The largest Vivani Medical seller in Q4 2020 was Versant Venture Management, an estimated $484K sold.

Based on aggregated 13F filings for Q4 2020.